Günter Höglinger

Professor Günter Höglinger serves as a faculty member in the Department of Neurology at Ludwig Maximilian University of Munich's Faculty of Medicine, based at University Hospital of Munich (Campus Großhadern) and leading the German Center for Vertigo and Balance Disorders (IFB).

His research program targets neurodegenerative mechanisms with dual clinical focus: movement disorders (Parkinson's disease, Progressive Supranuclear Palsy, multisystem atrophy) and vestibular pathologies. Key methodologies include molecular therapy development (siRNA), neuroinflammation modeling, and multi-omics integration to identify therapeutic targets. The German Center for Vertigo and Balance Disorders provides specialized clinical and research infrastructure for translational studies.

Professor Höglinger's scientific recognition includes the prestigious Heisenberg Professorship from the German Research Foundation (DFG), awarded for his work on Progressive Supranuclear Palsy. His completed DFG projects demonstrate sustained funding success in high-impact areas:

• Inflammation mechanisms in Parkinson's disease models
• siRNA therapeutics for tauopathies
• Multi-omics approaches for multisystem atrophy interventions

His research group operates at the intersection of clinical neurology and molecular neuroscience, maintaining active investigation into disease mechanisms while developing novel treatment strategies for debilitating neurodegenerative conditions through the IFB platform.